Literature DB >> 26950221

Reasons for non-participation in scleroderma support groups.

Vanessa C Delisle1, Stephanie T Gumuchian2, Sandra Pelaez3, Vanessa L Malcarne4, Ghassan El-Baalbaki5, Annett Körner6, Marie Hudson7, Murray Baron7, Brett D Thombs8.   

Abstract

OBJECTIVES: Peer-led support groups are an important resource for people living with many rare diseases, including scleroderma (systemic sclerosis, SSc). Little is known, however, about the accessibility of SSc support groups and factors that may discourage people from participating in these groups. The objective of this study was to identify reasons why people with SSc do not participate in SSc support groups.
METHODS: Canadians with SSc were recruited to complete the Canadian Scleroderma Patient Survey of Health Concerns and Research Priorities. Data from respondents who answered the question "Have you participated in SSc support groups?" with "No" were analyzed. Frequencies of participants who responded (1) I'm not interested, (2) None are easily available, and (3) Other (please specify) were tallied. A content analysis approach was used to code the open-ended responses to this question.
RESULTS: A total of 280 respondents provided a reason for non-participation in SSc support groups. Key reasons for not participating in support groups included: (1) Not interested or no perceived need (36%); (2) No local support group available (35%); (3) Lack of awareness of the existence of SSc support groups (13%); (4) Practical barriers (6%); (5) Emotional factors (4%); (6) Uncertainty about whether to attend (4%); and (7) Negative perceptions about support groups (3%).
CONCLUSIONS: SSc organizations may be able to address current limitations in the accessibility and effectiveness of SSc support groups by implementing online support groups, as well as by providing support group leaders training to help establish and sustain successful SSc support groups.

Entities:  

Mesh:

Year:  2016        PMID: 26950221

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  11 in total

Review 1.  Comparison of Self-Efficacy for Managing Chronic Disease between patients with systemic sclerosis and other chronic conditions: a systematic review.

Authors:  Brett D Thombs; Linda Kwakkenbos; Kira E Riehm; Nazanin Saadat; Claire Fedoruk
Journal:  Rheumatol Int       Date:  2016-11-19       Impact factor: 2.631

2.  Reasons for attending support groups and organizational preferences: A replication study using the North American Scleroderma Support Group Survey.

Authors:  Mia Pépin; Linda Kwakkenbos; Marie-Eve Carrier; Sandra Peláez; Ghassan El-Baalbaki; Vanessa L Malcarne; Brett D Thombs
Journal:  J Scleroderma Relat Disord       Date:  2019-05-29

3.  Development and preliminary validation of the Scleroderma Support Group Leader Self-efficacy Scale.

Authors:  Nicole E Pal; Stephanie T Gumuchian; Vanessa C Delisle; Mia Pépin; Vanessa L Malcarne; Marie-Eve Carrier; Linda Kwakkenbos; Sandra Peláez; Ghassan El-Baalbaki; Brett D Thombs
Journal:  J Scleroderma Relat Disord       Date:  2017-09-25

4.  Implementing psychosocial programming at a level 1 trauma center: results from a 5-year period.

Authors:  Natasha M Simske; Trenton Rivera; Mary A Breslin; Sarah B Hendrickson; Megen Simpson; Mark Kalina; Vanessa P Ho; Heather A Vallier
Journal:  Trauma Surg Acute Care Open       Date:  2020-01-21

Review 5.  Effect of support group peer facilitator training programmes on peer facilitator and support group member outcomes: a systematic review.

Authors:  Vanessa C Delisle; Stephanie T Gumuchian; Lorie A Kloda; Jill Boruff; Ghassan El-Baalbaki; Annett Körner; Vanessa L Malcarne; Brett D Thombs
Journal:  BMJ Open       Date:  2016-11-17       Impact factor: 2.692

6.  Use of the nominal group technique to identify stakeholder priorities and inform survey development: an example with informal caregivers of people with scleroderma.

Authors:  Danielle B Rice; Mara Cañedo-Ayala; Kimberly A Turner; Stephanie T Gumuchian; Vanessa L Malcarne; Mariët Hagedoorn; Brett D Thombs
Journal:  BMJ Open       Date:  2018-03-02       Impact factor: 2.692

7.  Effects of training and support programs for leaders of illness-based support groups: commentary and updated evidence.

Authors:  Kimberly A Turner; Danielle B Rice; Andrea Carboni-Jiménez; Jill Boruff; Brett D Thombs
Journal:  Syst Rev       Date:  2019-03-05

8.  Implementation of programming for survivors of violence-related trauma at a level 1 trauma center.

Authors:  Natasha M Simske; Trenton Rivera; Bryan O Ren; Alex Benedick; Megen Simpson; Mark Kalina; Sarah B Hendrickson; Heather A Vallier
Journal:  Trauma Surg Acute Care Open       Date:  2021-10-07

9.  Study design and characteristics of the Luxembourg European Health Examination Survey (EHES-LUX).

Authors:  Valéry Bocquet; Jessica Barré; Sophie Couffignal; Marylène d'Incau; Charles Delagardelle; Georges Michel; Marc Schlesser; Saverio Stranges; Andrea Kuemmerle; Maria Ruiz-Castell
Journal:  BMC Public Health       Date:  2018-10-11       Impact factor: 3.295

10.  Scleroderma Patient-centered Intervention Network-Scleroderma Support group Leader EDucation (SPIN-SSLED) program: non-randomised feasibility trial.

Authors:  Brett D Thombs; Laura Dyas; Mia Pépin; Kylene Aguila; Marie-Eve Carrier; Lydia Tao; Sami Harb; Vanessa L Malcarne; Ghassan El-Baalbaki; Sandra Peláez; Maureen Sauve; Marie Hudson; Robert W Platt
Journal:  BMJ Open       Date:  2019-11-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.